05Aug
Defying gravity: US M&A H1 2019: Pharma chases innovation through deals
The need to replenish intellectual property has pushed the pharma industry to the highest-performing sector by M&A value. In the pharmaceuticals, medical and biotech sector, deal value in the first half of the year was up 142 percent to US$172...
By:
White & Case LLP
Related
In a decision dated 25 November 2020, the Criminal Chamber of the French “Cour de Cassation” decid...
Read More >
Italy – Italian Government acts to facilitate equity injections in Italian companies - With Law De...
Read More >
The Ontario Court of Appeal recently released the second of two highly anticipated decisions stemmin...
Read More >
On January 10, 2020 the United States Department of Justice (DOJ) and the Federal Trade Commission (...
Read More >
The Law - On September 19, 2019, Governor Gavin Newsom signed Assembly Bill 5 (AB 5) into law. The ...
Read More >
Employers in Pennsylvania that require licenses as a condition of employment may have to revisit the...
Read More >